Skip to main content
SpringerLink
Log in

Mechanisms of Prion Toxicity and Their Relationship to Prion Infectivity

  • Chapter
Neurodegeneration and Prion Disease

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. S. B. Prusiner, Novel proteinaceous infectious particles cause scrapie. Science 216, 136–44 (1982).

    Google Scholar 

  2. H. Bueler, A. Aguzzi, A. Sailer, R. A. Greiner, P. Autenried, M. Aguet and C. Weissmann, Mice devoid of PrP are resistant to scrapie. Cell 73, 1339–47 (1993).

    Article  PubMed  Google Scholar 

  3. S. Brandner, S. Isenmann, A. Raeber, M. Fischer, A. Sailer, Y. Kobayashi, S. Marino, C. Weissmann and A. Aguzzi, Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339–43 (1996).

    Article  PubMed  Google Scholar 

  4. D. R. Borchelt, M. Scott, A. Taraboulos, N. Stahl and S. B. Prusiner, Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol 110, 743–52 (1990).

    PubMed  Google Scholar 

  5. D. A. Kocisko, J. H. Come, S. A. Priola, B. Chesebro, G. J. Raymond, R. T. Lansbury and B. Caughey, Cell-free formation of protease-resistant prion protein. Nature 370, 471–4 (1994).

    PubMed  Google Scholar 

  6. S. K. DebBurman, G. J. Raymond, B. Caughey and S. Lindquist, Chaperone-supervised conversion of prion protein to its protease-resistant form. Proc Natl Acad Sci USA 94, 13938–43 (1997).

    PubMed  Google Scholar 

  7. J. Chabry, S. A. Priola, K. Wehrly, J. Nishio, J. Hope and B. Chesebro, Species-independent inhibition of abnormal prion protein (PrP) formation by a peptide containing a conserved PrP sequence. J Virol 73, 6245–50 (1999).

    PubMed  Google Scholar 

  8. A. F. Hill, M. Antoniou and J. Collinge, Protease-resistant prion protein produced in vitro lacks detectable infectivity. J Gen Virol 80 ( Pt 1), 11–4 (1999).

    PubMed  Google Scholar 

  9. C. L. Masters, G. Simms, N. A. Weinman, G. Multhaup, B. L. McDonald and K. Beyreuther, Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82, 4245–9 (1985).

    PubMed  Google Scholar 

  10. B. A. Yankner, L. R. Dawes, S. Fisher, L. Villa-Komaroff, M. L. Oster-Granite and R. L. Neve, Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer’s disease. Science 245, 417–20 (1989).

    PubMed  Google Scholar 

  11. R. L Neve, L R. Dawes, B. A. Yankner, L I. Benowitz, W. Rodriguez and G. A. Higgins, Genetics and biology of the Alzheimer amyloid precursor. Prog Brain Res 86, 257–67 (1990).

    PubMed  Google Scholar 

  12. G. Forloni, N. Angeretti, R. Chiesa, E. Monzani, M. Salmona, O. Bugiani and F Tagliavini, Neurotoxicity of a prion protein fragment. Nature 362, 543–6 (1993).

    Article  PubMed  Google Scholar 

  13. D. R. Brown, J. Herms and H. A. Kretzschmar, Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment. Neuroreport 5, 2057–60 (1994).

    PubMed  Google Scholar 

  14. S. B. Prusiner, Prions. Proc Natl Acad Sci USA 95, 13363–83 (1998).

    Article  PubMed  Google Scholar 

  15. H. Budka, A. Aguzzi, P. Brown, J. M. Brucher, O. Bugiani, F. Gullotta, M. Haltia, J. J. Hauw, J. W. Ironside, K. Jellingerandetal., Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 5, 459–66 (1995).

    PubMed  Google Scholar 

  16. C. Selvaggini, L. De Gioia, L. Cantu, E. Ghibaudi, L. Diomede, F. Passerini, G. Forloni, O. Bugiani, F. Tagliavini and M. Salmona, Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106–126 of the prion protein. Biochem Biophys Res Commun 194, 1380–6 (1993).

    PubMed  Google Scholar 

  17. L. De Gioia, C. Selvaggini, E. Ghibaudi, L. Diomede, O. Bugiani, G. Forloni, F. Tagliavini and M. Salmona, Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106–126 of the prion protein. J Biol Chem 269, 7859–62 (1994).

    PubMed  Google Scholar 

  18. M. F. Jobling, L. R. Stewart, A. R. White, C. McLean, A. Friedhuber, F. Maher, K. Beyreuther, C. L. Masters, C. J. Barrow, S. J. Collinsand R. Cappai, The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106–126. J Neurochem 73, 1557–65 (1999).

    PubMed  Google Scholar 

  19. M. Salmona, P. Malesani, L. De Gioia, S. Gorla, M. Bruschi, A. Molinari, F. Della Vedova, B. Pedrotti, M. A. Marrari, T. Awan, O. Bugiani, G. Forloni and F. Tagliavini, Molecular determinants of the physicochemical propertiesof a critical prion protein region comprising residues 106–126. Biochem J 342 ( Pt 1), 207–14 (1999).

    PubMed  Google Scholar 

  20. M. Bucciantini, E. Giannoni, F. Chiti, F. Baroni, L. Formigli, J. Zurdo, N. Taddei, G. Ramponi, C. M. Dobson and M. Stefani, Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507–11 (2002).

    PubMed  Google Scholar 

  21. A. Corsaro, S. Thellung, V Villa, D. R. Principe, D. Paludi, S. Arena, E. Millo, D. Schettini, G. Damonte, A. Aceto, G. Schettini and T. Florio, Prion protein fragment 106–126 induces a p38 MAP kinase-dependent apoptosis in SH-SY5Y neuroblastoma cells independently from the amyloid fibril formation. Ann NY Acad Sci 1010, 610–22 (2003).

    PubMed  Google Scholar 

  22. D. R. Brown, M. Pitschke, D. Riesnerand H. A. Kretzschmar, Cellular effects of a neurotoxic prion protein are related to its ß-sheet content. Neurosci. Res. Comm. 23, 119–128 (1998).

    Google Scholar 

  23. T. Oda, P. Wals, H. H. Osterburg, S. A. Johnson, G. M. Pasinetti, T. E. Morgan, I. Rozovsky, W. B. Stine, S. W. Snyder, T F. Holzman and et al., Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1–42) and forms slowly sedimenting A beta complexes that cause oxidative stress. Exp Neurol 136, 22–31 (1995).

    PubMed  Google Scholar 

  24. M. P. Lambert, A. K. Barlow, B. A. Chromy, C. Edwards, R. Freed, M. Liosatos, T. E. Morgan, I. Rozovsky, B. Trommer, K. L. Viola, P. Wals, C. Zhang, C. E. Finch, G. A. Krafft and W. L. Klein, Diffusible, nonfibrillar ligands derived from Abeta 1–42 are potent central nervous system neurotoxins. PNAS 95, 6448–6453 (1998).

    PubMed  Google Scholar 

  25. D. R. Brown, Prion protein-overexpressing cells show altered response to a neurotoxic prion protein peptide. J Neurosci Res 54, 331–40 (1998).

    PubMed  Google Scholar 

  26. D. R. Brown, A. Besinger, J. W. Herms and H. A. Kretzschmar, Microglial expression of the prion protein. Neuroreport, 9 1425–9 (1998).

    PubMed  Google Scholar 

  27. D. R. Brown, B. Schmidt and H. A. Kretzschmar, A prion protein fragment primes type 1 astrocytes to proliferation signals from microglia. Neurobiol Dis 4, 410–22 (1998).

    Article  PubMed  Google Scholar 

  28. A. Giese, D. R. Brown, M. H. Groschup, C. Feldmann, I. Haist and H. A. Kretzschmar, Role of microglia in neuronal cell death in prion disease. Brain Pathol 8, 449–57 (1998).

    PubMed  Google Scholar 

  29. R. N. Kalaria, Microglia and Alzheimer’s disease. Curr Opin Hematol 6, 15–24 (1999).

    PubMed  Google Scholar 

  30. S. Itagaki, R L. McGeer, H. Akiyama, S. Zhuand D. Selkoe, Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol 24, 173–82 (1989).

    PubMed  Google Scholar 

  31. A. Williams, R J. Lucassen, D. Ritchie and M. Bruce, PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie. Exp Neurol 144, 433–8 (1997).

    PubMed  Google Scholar 

  32. P. J. Lucassen, A. Williams, W. C. Chung and H. Fraser, Detection of apoptosis in murine scrapie. Neurosci Lett 198, 185–8 (1995).

    PubMed  Google Scholar 

  33. A. E. Williams, L. J. Lawson, V H. Perry and H. Fraser, Characterization of the microglial response in murine scrapie. Neuropathol Appl Neurobiol 20, 47–55 (1994).

    PubMed  Google Scholar 

  34. D. C. Guiroy, I. Wakayama, P. P. Liberski and D. C. Gajdusek, Relationship of microglia and scrapie amyloid-immunoreactive plaques in kuru, Creutzfeldt-Jakob disease and Gerstmann-Straussler syndrome. Acta Neuropathol (Berl) 87, 526–30 (1994).

    Google Scholar 

  35. J. W. Ironside, L. McCardle, R A. Hayward and J. E. Bell, Ubiquitin immunocyto-chemistry in human spongiform encephalopathies. Neuropathol Appl Neurobiol 19, 134–40 (1993).

    PubMed  Google Scholar 

  36. M. Miyazono, T. Iwaki, T. Kitamoto, Y Kaneko, K. Doh-ura and J. Tateishi, A comparative immunohistochemical study of Kuru and senile plaques with a special reference to glial reactions at various stages of amyloid plaque formation. Am J Pathol 139, 589–98 (1991).

    PubMed  Google Scholar 

  37. S. Betmouni, V H. Perry and J. L. Gordon, Evidence for an early inflammatory response in the central nervous system of mice with scrapie. Neuroscience 74, 1–5 (1996).

    PubMed  Google Scholar 

  38. J. M. Peyrin, C. I. Lasmezas, S. Haik, F. Tagliavini, M. Salmona, A. Williams, D. Richie, J. P. Deslys and D. Dormont, Microglial cells respond to amyloidogenic PrP peptide bythe production of inflammatory cytokines. Neuroreport 10, 723–9 (1999).

    PubMed  Google Scholar 

  39. V. Silei, C. Fabrizi, G. Venturini, M. Salmona, O. Bugiani, F Tagliavini and G. M. Lauro, Activation of microglial cells by PrP and beta-amyloid fragments raises intracellular calcium through L-type voltage sensitive calcium channels. Brain Res 818, 168–70 (1999).

    PubMed  Google Scholar 

  40. D. R. Brown and H. A. Kretzschmar, Microglia and prion disease: a review. Histol Histopathol 12, 883–92 (1997).

    PubMed  Google Scholar 

  41. D. Lorton, J. M. Kocsis, L. King, K. Madden and K. R. Brunden, beta-Amyloid induces increased release of interleukin-1 beta from lipopolysaccharide-activated human monocytes. J Neuroimmunol 67, 21–9 (1996).

    PubMed  Google Scholar 

  42. S. L. Yates, L. H. Burgess, J. Kocsis-Angle, J. M. Antal, M. D. Dority, R B. Embury, A. M. Piotrkowski and K. R. Brunden, Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia. J Neurochem 74, 1017–25 (2000).

    PubMed  Google Scholar 

  43. C. K. Combs, D. E. Johnson, S. B. Cannady, T M. Lehman and G. E. Landreth, Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins. J Neurosci 19, 928–39 (1999).

    PubMed  Google Scholar 

  44. J. A. Hamilton, G. Whitty A. R. White, M. F Jobling, A. Thompson, C. J. Barrow, R. Cappai, K. Beyreuther and C. L. Masters, Alzheimer’s disease amyloid beta and prion protein amyloidogenic peptides promote macrophage survival, DNA synthesis and enhanced proliferative response to CSF-1 (M-CSF). Brain Res 940, 49–54 (2002).

    PubMed  Google Scholar 

  45. K. Jendroska, F. P. Heinzel, M. Torchia, L. Stowring, H. A. Kretzschmar, A. Kon, A. Stern, S. B. Prusiner and S. J. DeArmond, Proteinase-resistant prion protein accumulation in Syrian hamster brain correlates with regional pathology and scrapie infectivity. Neurology 41, 1482–90 (1991).

    PubMed  Google Scholar 

  46. S. J. DeArmond, S. L. Yang, A. Lee, R. Bowler, A. Taraboulos, D. Groth and S. B. Prusiner, Three scrapie prion isolates exhibit different accumulation patterns of the prion protein scrapie isoform. Proc Natl Acad Sci USA 90, 6449–53 (1993).

    PubMed  Google Scholar 

  47. H. McLennan and H. V. Wheal, The interaction of glutamic and aspartic acids with excitatory amino acid receptors in the mammalian central nervous system. Can J Physiol Pharmacol 54, 70–2 (1976).

    PubMed  Google Scholar 

  48. G. Garthwaite, G. D. Williams and J. Garthwaite, Glutamate Toxicity: An Experimental and Theoretical Analysis. Eur J Neurosci 4, 353–360 (1992).

    PubMed  Google Scholar 

  49. D. R. Brown, J. W. Herms, B. Schmidt and H. A. Kretzschmar, PrP and beta-amyloid fragments activate different neurotoxic mechanisms in cultured mouse cells. Eur J Neurosci 9, 1162–9 (1997).

    PubMed  Google Scholar 

  50. W. E. Muller, H. Ushijima, H. C. Schroder, J. M. Forrest, W. F. Schatton, R G. Rytik and M. Heffner-Lauc, Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures. Eur J Pharmacol 246, 261–7 (1993).

    PubMed  Google Scholar 

  51. S. Perovic, G. Pergande, H. Ushijima, M. Kelve, J. Forrestand W. E. Muller, Flupirtine partially prevents neuronal injury induced by prion protein fragment and lead acetate. Neurodegeneration 4, 369–74 (1995).

    PubMed  Google Scholar 

  52. H. C. Schroder, S. Perovic, V Kavsan, H. Ushijima and W. E. Muller, Mechanisms of prionSc-and HIV-1 gp120 induced neuronal cell death. Neurotoxicology 19, 683–8 (1998).

    PubMed  Google Scholar 

  53. B. Miller, M. Sarantis, S. F. Traynelis and D. Attwell, Potentiation of NMDA receptor currents by arachidonic acid. Nature 355, 722–5 (1992).

    PubMed  Google Scholar 

  54. B. Barbour, M. Szatkowski, N. Ingledewand D. Attwell, Arachidonic acid induces a prolonged inhibition of glutamate uptake into glial cells. Nature 342, 918–20 (1989).

    PubMed  Google Scholar 

  55. A. Dumuis, M. Sebben, L. Haynes, J. R. Pin and J. Bockaert, NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature 336, 68–70 (1988).

    PubMed  Google Scholar 

  56. L. R. Stewart, A. R. White, M. F Jobling, B. E. Needham, F. Maher, J. Thyer, K. Beyreuther, C. L. Masters, S. J. Collins and R. Cappai, Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106–126. J Neurosci Res 65, 565–72 (2001).

    PubMed  Google Scholar 

  57. C. Korth, B. C. May, F E. Cohen and S. B. Prusiner, Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci USA 98, 9836–41 (2001).

    PubMed  Google Scholar 

  58. A. Barret, F. Tagliavini, G. Forloni, C. Bate, M. Salmona, L. Colombo, A. De Luigi, L. Limido, S. Suardi, G. Rossi, F Auvre, K. T Adjou, N. Sales, A. Williams, C. Lasmezas and J. P. Deslys, Evaluation of quinacrine treatmentfor prion diseases. J Virol 77, 8462–9 (2003).

    PubMed  Google Scholar 

  59. M. Daniels, G. M. Cereghetti and D. R. Brown, Toxicity of novel C-terminal prion protein fragments and peptides harbouring disease-related C-terminal mutations. Eur J Biochem 268, 6155–64 (2001).

    PubMed  Google Scholar 

  60. F. B. Hafiz and D. R. Brown, A model for the mechanism of astrogliosis in prion disease. Mol Cell Neurosci 16, 221–32 (2000).

    PubMed  Google Scholar 

  61. D. R. Brown, Prion protein peptide neurotoxicity can be mediated by astrocytes. J Neurochem 73, 1105–13 (1999).

    PubMed  Google Scholar 

  62. E. T Dayton and E. O. Major, Recombinant human interleukin 1 beta induces production of prostaglandins in primary human fetal astrocytes and immortalized human fetal astrocyte cultures. J Neuroimmunol 71, 11–8 (1996).

    PubMed  Google Scholar 

  63. N. Stella, A. Estelles, J. Siciliano, M. Tence, S. Desagher, D. Piomelli, J. Glowinski and J. Premont, Interleukin-1 enhances the ATP-evoked release of arachidonic acid from mouse astrocytes. J Neurosci 17, 2939–46 (1997).

    PubMed  Google Scholar 

  64. M. Moser, R. J. Colello, U. Pott and B. Oesch, Developmental expression of the prion protein gene in glial cells. Neuron 14, 509–17 (1995).

    PubMed  Google Scholar 

  65. A. J. Raeber, R. E. Race, S. Brandner, S. A. Priola, A. Sailer, R. A. Bessen, L Mucke, J. Manson, A. Aguzzi, M. B. Oldstone, C. Weissmann and B. Chesebro, Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamsterscrapie. EMBO J 16, 6057–65 (1997).

    PubMed  Google Scholar 

  66. J. Sassoon, M. Daniels and D. R. Brown, Astrocytic regulation of NMDA receptor subunit composition modulates the toxicity of prion peptide PrP106–126. Mol Cell Neurosci 25, 181–91 (2004).

    PubMed  Google Scholar 

  67. D. R. Brown and C. M. Mohn, Astrocytic glutamate uptake and prion protein expression. Glia 25, 282–92 (1999).

    PubMed  Google Scholar 

  68. N. Vassallo and J. Herms, Cellular prion protein function in copper homeostasis and redox signalling at the synapse. J Neurochem 86, 538–44 (2003).

    PubMed  Google Scholar 

  69. D. R. Brown, K. Qin, J. W. Herms, A. Madlung, J. Manson, R. Strome, R E. Fraser, T. Kruck, A. von Bohlen, W. Schulz-Schaeffer, A. Giese, D. Westaway and H. Kretzschmar, The cellular prion protein binds copper in vivo. Nature 390, 684–7 (1997).

    PubMed  Google Scholar 

  70. J. Stockel, J. Safar, A. C. Wallace, F E. Cohen and S. B. Prusiner, Prion protein selectively binds copper(II) ions. Biochemistry 37, 7185–93 (1998).

    PubMed  Google Scholar 

  71. M. P. Hornshaw, J. R. McDermott, J. M. Candyand J. H. Lakey, Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein: structural studies using synthetic peptides. Biochem Biophys Res Commun 214, 993–9 (1995).

    PubMed  Google Scholar 

  72. D. R. Brown, F. Hafiz, L. L. Glasssmith, B. S. Wong, I. M. Jones, C. Clive and S. J. Haswell, Consequences of manganese replacement of copper for prion protein function and proteinase resistance. EMBO J 19, 1180–6 (2000).

    PubMed  Google Scholar 

  73. B. S. Wong, D. R. Brown, T Pan, M. Whiteman, T. Liu, X. Bu, R. Li, P. Gambetti, J. Olesik, R. Rubenstein and M. S. Sy, Oxidative impairment in scrapie-infected mice is associated with brain metals perturbations and altered antioxidant activities. J Neurochem 79, 689–98 (2001).

    PubMed  Google Scholar 

  74. A. M. Thackray R. Knight, S. J. Haswell, R. Bujdoso and D. R. Brown, Metal imbalance and compromised antioxidant function are early changes in prion disease. Biochem J 362, 253–8 (2002).

    PubMed  Google Scholar 

  75. H. A. Kretzschmar, L. E. Stowring, D. Westaway, W. H. Stubblebine, S. B. Prusiner and S. J. Dearmond, Molecular cloning of a human prion protein cDNA. DNA 5, 315–24 (1986).

    PubMed  Google Scholar 

  76. J. M. Gabriel, B. Oesch, H. Kretzschmar, M. Scott and S. B. Prusiner, Molecular cloning of a candidate chicken prion protein. Proc Natl Acad Sci USA 89, 9097–101 (1992).

    PubMed  Google Scholar 

  77. B. Belosi, E. Gaggelli, R. Guerrini, H. Kozlowski, M. Luczkowski, F. M. Mancini, M. Remelli, D. Valensin and G. Valensin, Copper binding to the neurotoxic peptide PrP106–126: thermodynamic and structural studies. Chembiochem 5, 349–59 (2004).

    PubMed  Google Scholar 

  78. E. Wong, A. M. Thackray and R. Bujdoso, Copper induces increased beta-sheet content in the scrapie-susceptible ovine prion protein PrPVRQ compared with the resistant allelic variant PrPARR. Biochem J 380, 273–82 (2004).

    PubMed  Google Scholar 

  79. T. Miura, A. Hori-i and H. Takeuchi, Metal-dependent alpha-helix formation promoted by the glycine-rich octapeptide region of prion protein. FEBS Lett 396, 248–52 (1996).

    PubMed  Google Scholar 

  80. M. F. Jobling, X. Huang, L. R. Stewart, K. J. Barnham, C. Curtain, I. Volitakis, M. Perugini, A. R. White, R. A. Cherny, C. L. Masters, C. J. Barrow, S. J. Collins, A. I. Bush and R. Cappai, Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106–126. Biochemistry 40, 8073–84 (2001).

    PubMed  Google Scholar 

  81. D. R. Brown and A. Besinger, Prion protein expression and superoxide dismutase activity. Biochem J 334 (Pt 2), 423–9 (1998).

    PubMed  Google Scholar 

  82. F. Klamt, F. Dal-Pizzol, M. J. Conte da Frota, R. Walz, M. E. Andrades, E. G. da Silva, R. R. Brentani, I. Izquierdo and J. C. Fonseca Moreira, Imbalance of antioxidant defense in mice lacking cellular prion protein. Free Radic Biol Med 30, 1137–44 (2001).

    PubMed  Google Scholar 

  83. D. R. Brown, R. S. Nicholas and L. Canevari, Lack of prion protein expression results in a neuronal phenotype sensitive to stress. J Neurosci Res 67, 211–24 (2002).

    PubMed  Google Scholar 

  84. D. R. Brown and J. Sassoon, Copper-dependent functions for the prion protein. Mol Biotechnol 22, 165–78 (2002).

    PubMed  Google Scholar 

  85. R C. Pauly and D. A. Harris, Copperstimulates endocytosis of the prion protein. J Biol Chem 273, 33107–10 (1998).

    PubMed  Google Scholar 

  86. W. Rachidi, A. Mange, A. Senator, P. Guiraud, J. Riondel, M. Benboubetra, A. Favier and S. Lehmann, Prion infection impairs copper binding of cultured cells. J Biol Chem 278, 14595–8 (2003).

    PubMed  Google Scholar 

  87. D. R. Brown, Role of the prion protein in copperturnover in astrocytes. Neurobiol Dis 15, 534–43 (2004).

    PubMed  Google Scholar 

  88. J. Collinge, M. A. Whittington, K. C. Sidle, C. J. Smith, M. S. Palmer, A. R. Clarke and J. G. Jefferys, Prion protein is necessary for normal synaptic function. Nature 370, 295–7 (1994).

    PubMed  Google Scholar 

  89. M. A. Whittington, K. C. Sidle, I. Gowland, J. Meads, A. F. Hill, M. S. Palmer, J. G. Jefferys and J. Collinge, Rescue of neurophysiological phenotype seen in PrP null mice by transgene encoding human prion protein. Nat Genet 9, 197–201 (1995).

    PubMed  Google Scholar 

  90. S. B. Colling, J. Collinge and J. G. Jefferys, Hippocampal slices from prion protein null mice: disrupted Ca(2+)-activated K+ currents. Neurosci Lett 209, 49–52 (1996).

    PubMed  Google Scholar 

  91. G. R. Mallucci, S. Ratte, E. A. Asante, J. Linehan, I. Gowland, J. G. Jefferys and J. Collinge, Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J 21, 202–10 (2002).

    PubMed  Google Scholar 

  92. K. Kristensson, B. Feuerstein, A. Taraboulos, W. C. Hyun, S. B. Prusiner and S. J. DeArmond, Scrapie prions alter receptor-mediated calcium responses in cultured cells. Neurology 43, 2335–2341 (1993).

    PubMed  Google Scholar 

  93. K. Wong, Y. Qiu, W. Hyun, R. Nixon, J. VanCleff, J. Sanchez-Salazar, S. B. Prusiner and S. J. DeArmond, Decreased receptor-mediated calcium response in prion-infected cells correlates with decreased membrane fluidity and IP3 release. Neurology 47, 741–750 (1996).

    PubMed  Google Scholar 

  94. A. R. Johnston, J. R. Fraser, M. Jeffrey and N. MacLeod, Synaptic plasticity in the CA1 area of the hippocampus of scrapie-infected mice. Neurobiol Dis 5, 188–95 (1998).

    PubMed  Google Scholar 

  95. R A. Barrow, C. D. Holmgren, A. J. Tapper and J. G. Jefferys, Intrinsic physiological and morphological properties of principal cells of the hippocampus and neocortex in hamsters infected with scrapie. Neurobiol Dis 6, 406–23 (1999).

    PubMed  Google Scholar 

  96. T. Florio, S. Thellung, C. Amico, M. Robello, M. Salmona, O. Bugiani, F Tagliavini, G. Forloni and G. Schettini, Prion protein fragment 106–126 induces apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in the GH3 cell line. J Neurosci Res 54, 341–52 (1998).

    PubMed  Google Scholar 

  97. T. Florio, M. Grimaldi, A. Scorziello, M. Salmona, O. Bugiani, F. Tagliavini, G. Forloni and G. Schettini, Intracellular calcium rise through L-type calcium channels, as molecular mechanism for prion protein fragment 106–126-induced astroglial proliferation. Biochem Biophys Res Commun 228, 397–405 (1996).

    Article  PubMed  Google Scholar 

  98. S. Thellung, T. Florio, V Villa, A. Corsaro, S. Arena, C. Amico, M. Robello, M. Salmona, G. Forloni, O. Bugiani, F. Tagliavini and G. Schettini, Apoptotic cell death and impairmentof L-type voltage-sensitive calcium channel activity in ratcerebellar granule cells treated with the prion protein fragment 106–126. Neurobiol Dis 7, 299–309 (2000).

    PubMed  Google Scholar 

  99. A. Thompson, A. R. White, C. McLean, C. L. Masters, R. Cappai and C. J. Barrow, Amyloidogenicity and neurotoxicity of peptides corresponding to the helical regions of PrP(C). J Neurosci Res 62, 293–301 (2000).

    PubMed  Google Scholar 

  100. G. Forloni, N. Angeretti, P. Malesani, E. Peressini, T Rodriguez Martin, R. Della Torreand M. Salmona, Influence of mutations associated with familial prion-related encephalopathies on biological activity of prion protein peptides. Ann Neurol 45, 489–94 (1999).

    PubMed  Google Scholar 

  101. J. Nguyen, M. A. Baldwin, F E. Cohen and S. B. Prusiner, Prion protein peptides induce alpha-helix to beta-sheet conformational transitions. Biochemistry 34, 4186–92 (1995).

    PubMed  Google Scholar 

  102. H. Zhang, K. Kaneko, J. T. Nguyen, T. L. Livshits, M. A. Baldwin, F. E. Cohen, T. L. James and S. B. Prusiner, Conformational transitions in peptides containing two putative alpha-helices of the prion protein. J Mol Biol 250, 514–26 (1995).

    PubMed  Google Scholar 

  103. F. Tagliavini, F. Prelli, L. Verga, G. Giaccone, R. Sarma, P. Gorevic, B. Ghetti, F. Passerini, E. Ghibaudi, G. Forloni and et al., Synthetic peptides homologous to prion protein residues 106–147 form amyloid-like fibrils in vitro. Proc Natl Acad Sci USA 90, 9678–82 (1993).

    PubMed  Google Scholar 

  104. M. Fischer, T. Rulicke, A. Raeber, A. Sailer, M. Moser, B. Oesch, S. Brandner, A. Aguzzi and C. Weissmann, Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J 15, 1255–64 (1996).

    PubMed  Google Scholar 

  105. E. Flechsig, D. Shmerling, I. Hegyi, A. J. Raeber, M. Fischer, A. Cozzio, C. von Mering, A. Aguzzi and C. Weissmann, Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. Neuron 27, 399–408 (2000).

    PubMed  Google Scholar 

  106. D. Shmerling, I. Hegyi, M. Fischer, T. Blattler, S. Brandner, J. Gotz, T. Rulicke, E. Flechsig, A. Cozzio, C. von Mering, C. Hangartner, A. Aguzzi and C. Weissmann, Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93, 203–14 (1998).

    PubMed  Google Scholar 

  107. S. Supattapone, P. Bosque, T. Muramoto, H. Wille, C. Aagaard, D. Peretz, H. O. Nguyen, C. Heinrich, M. Torchia, J. Safar, F E. Cohen, S. J. DeArmond, S. B. Prusiner and M. Scott, Prion protein of 106 residues creates an artifical transmission barrierfor prion replication in transgenic mice. Cell 96, 869–78 (1999).

    PubMed  Google Scholar 

  108. V Bonetto, T. Massignan, R. Chiesa, M. Morbin, G. Mazzoleni, L. Diomede, N. Angeretti, L. Colombo, G. Forloni, F Tagliavini and M. Salmona, Synthetic miniprion PrP106. J Biol Chem 277, 31327–34 (2002).

    PubMed  Google Scholar 

  109. R. H. Kimberlin and C. A. Walker, Pathogenesis of scrapie: agent multiplication in brain at the first and second passage of hamster scrapie in mice. J Gen Virol 42, 107–17 (1979).

    PubMed  Google Scholar 

  110. A. G. Dickinson, H. Fraserand G. W. Outram, Scrapie incubation time can exceed natural lifespan. Nature 256, 732–3 (1975).

    PubMed  Google Scholar 

  111. A. F Hill, S. Joiner, J. Linehan, M. Desbruslais, R L. Lantos and J. Collinge, Species-barrier-independent prion replication in apparently resistant species. Proc Natl Acad Sci USA 97, 10248–53 (2000).

    PubMed  Google Scholar 

  112. R. Race and B. Chesebro, Scrapie infectivity found in resistant species. Nature 392, 770 (1998).

    PubMed  Google Scholar 

  113. R. H. Kimberlin, C. A. Walker and H. Fraser, The genomic identity of different strains of mouse scrapie is expressed in hamsters and preserved on reisolation in mice. J Gen Virol 70 ( Pt 8), 2017–25 (1989).

    PubMed  Google Scholar 

  114. R. Race, A. Raines, G. J. Raymond, B. Caughey and B. Chesebro, Long-Term Subclinical Carrier State Precedes Scrapie Replication and Adaptation in a Resistant Species: Analogies to Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease in Humans. J. Virol. 75, 10106–10112 (2001).

    PubMed  Google Scholar 

  115. R. Frigg, M. A. Klein, I. Hegyi, R. M. Zinkernagel and A. Aguzzi, Scrapie pathogenesis in subclinically infected B-cell-deficient mice. J Virol 73, 9584–8 (1999).

    PubMed  Google Scholar 

  116. A. M. Thackray, M. A. Klein, A. Aguzzi and R. Bujdoso, Chronic Subclinical Prion Disease Induced by Low-Dose Inoculum. J. Virol. 76, 2510–2517 (2002).

    PubMed  Google Scholar 

  117. A. M. Thackray, M. A. Klein and R. Bujdoso, Subclinical Prion Disease Induced by Oral Inoculation. J. Virol. 77, 7991–7998 (2003).

    PubMed  Google Scholar 

  118. H. Bueler, A. Raeber, A. Sailer, M. Fischer, A. Aguzzi and C. Weissmann, High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene. Mol Med 1, 19–30 (1994).

    PubMed  Google Scholar 

  119. S. J. DeArmond, W. C. Mobley, D. L. DeMott, R. A. Barry, J. H. Beckstead and S. B. Prusiner, Changes in the localization of brain prion proteins during scrapie infection. Neurology 37, 1271–80 (1987).

    PubMed  Google Scholar 

  120. R. Gabizon, M. P. McKinley, D. Groth and S. B. Prusiner, Immunoaffinity purification and neutralization of scrapie prion infectivity. Proc Natl Acad Sci USA 85, 6617–21 (1988).

    PubMed  Google Scholar 

  121. R. Medori, P. Montagna, H. J. Tritschler, A. LeBlanc, P. Cortelli, P. Tinuper, E. Lugaresi and P. Gambetti, Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178. Neurology 42, 669–70 (1992).

    PubMed  Google Scholar 

  122. J. Collinge, F Owen, M. Poulter, M. Leach, T. J. Crow, M. N. Rossor, J. Hardy, M. J. Mullan, I. Janota and R L. Lantos, Prion dementia without characteristic pathology. Lancet 336, 7–9 (1990).

    PubMed  Google Scholar 

  123. J. Collinge, M. S. Palmer, K. C. Sidle, I. Gowland, R. Medori, J. Ironside and P. Lantos, Transmission of fatal familial insomnia to laboratory animals. Lancet 346, 569–70 (1995).

    PubMed  Google Scholar 

  124. A. F. Hill and J. Collinge, Subclinical prion infection. Trends in Microbiology 11, 578–584 (2003).

    PubMed  Google Scholar 

  125. C. I. Lasmezas, J. P. Deslys, O. Robain, A. Jaegly, V. Beringue, J. M. Peyrin, J. G. Fournier, J. J. Hauw, J. Rossier and D. Dormont, Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275, 402–5 (1997).

    PubMed  Google Scholar 

  126. A. Arjona, L. Simarro, F. Islinger, N. Nishida and L. Manuelidis, Two Creutzfeldt-Jakob disease agents reproduce prion protein-independent identities in cell cultures. Proc Natl Acad Sci U SA 101, 8768–73 (2004).

    Google Scholar 

  127. H. Bueler, M. Fischer, Y. Lang, H. Bluethmann, H. P. Lipp, S. J. DeArmond, S. B. Prusiner, M. Aguetand C. Weissmann, Normal developmentand behaviourof mice lacking the neuronal cell-surface PrP protein. Nature 356, 577–82 (1992).

    Article  PubMed  Google Scholar 

  128. R. S. Hegde, J. A. Mastrianni, M. R. Scott, K. A. DeFea, P. Tremblay, M. Torchia, S. J. DeArmond, S. B. Prusiner and V R. Lingappa, A transmembrane form of the prion protein in neurodegenerative disease. Science 279, 827–34 (1998).

    PubMed  Google Scholar 

  129. R. S. Hegde, P. Tremblay, D. Groth, S. J. DeArmond, S. B. Prusiner and V. R. Lingappa, Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature 402, 822–6 (1999).

    PubMed  Google Scholar 

  130. I. Sponne, A. Fifre, V Koziel, B. Kriem, T Oster, J. L. Olivierand T. Pillot, Oligoden-drocytes are susceptible to apoptotic cell death induced by prion protein-derived peptides. Glia 47, 1–8 (2004).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry and Molecular Biology, The University of Melbourne, Melbourne, Victoria, 3010, Australia

    Laura Vella & Andrew F. Hill

  2. Department of Pathology, The University of Melbourne, Melbourne, Victoria, 3010, Australia

    Laura Vella, Andrew F. Hill & Roberto Cappai

  3. The Centre for Neuroscience, The University of Melbourne, Melbourne, Victoria, 3010, Australia

    Andrew F. Hill & Roberto Cappai

Authors
  1. Laura Vella
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew F. Hill
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roberto Cappai
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Bath, UK

    David R. Brown

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Vella, L., Hill, A.F., Cappai, R. (2005). Mechanisms of Prion Toxicity and Their Relationship to Prion Infectivity. In: Brown, D.R. (eds) Neurodegeneration and Prion Disease. Springer, Boston, MA. https://doi.org/10.1007/0-387-23923-5_9

Download citation

Publish with us

Policies and ethics

Search

Navigation